Analyst Ratings for Seattle Genetics (sgen)

sgen Rating Summary

sgen Price Target Summary

* Over Last 12-Mos
  |   Expand Research on sgen
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $47.60 (+28.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/30/2014 BofA/Merrill Lynch Downgrade Underperform
(Neutral)
34.00
(40.00)
38.39 36.92 -3.83% Details
7/9/2014 UBS Upgrade Buy
(Neutral)
N/A
(N/A)
35.46 36.92 4.12% Details
Like SGEN Ratings? Also take a look at NDAQ, PCYC, RYAAY, MDVN

SGEN Ratings News